Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Size: px
Start display at page:

Download "Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections."

Transcription

1 In the name of God

2 Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress rapidly and may constitute medical emergencies. Infections are often advanced (ie, disseminated) at the time of clinical presentation because of impaired immunity. It is due to diminished symptoms and muted clinical and radiologic findings. Serologic testing is not generally useful for the diagnosis of acute infection in the immunocompromised host since seroconversion is often delayed. Altered anatomy following transplant surgery may change the physical signs of infection.

3 Principles of post Tx infections 2: Tissue biopsies i with histopathology th and microbiology are often needed to make a specific microbiologic diagnosis in transplant recipients. The choice of antimicrobial regimens is often more complex than in other patients due to the urgency of therapy and the frequency of drug toxicities iti and drug interactions. ti Antimicrobial resistance is increased in immunocompromised hosts and should be considered in the choice of antimicrobial regimens. Surgical intervention is often necessary to cure localized infections i (ie, debridement); antimicrobial i agents alone are frequently inadequate. Drug levels provide only crude means of monitoring immunosuppressive regimens and patients are often more or less immunosuppressed than anticipated.

4 Epidemiology of Post TX infections Community acquired pathogens respiratory viruses (influenza respiratory viruses (influenza, parainfluenza, respiratory syncytial [RSV] virus, adenovirus, and human metapneumovirus). In addition, common bacterial pathogens may include: Streptococcus pneumoniae, Mycoplasma, Legionella, Listeria monocytogenes, and Salmonella. Vaccinations for pneumococcus and influenza virus are useful but may have reduced efficacy in immunocompromised individuals. (See "Immunizations in solid organ transplant candidates and recipients".) In the appropriate geographic regions, endemic fungi (Histoplasma capsulatum, Coccidioides spp, Blastomyces dermatitidis, Cryptococcus gattii), and common environmental pathogens (eg, Cryptococcus neoformans, Aspergillus spp, Cryptosporidia spp) will be observed. Reactivation of infections Reactivated infection may be derived from the organ donor or the recipient. Common viral infections that frequently reactivate following transplantation include herpes simplex virus (HSV), CMV, varicella zoster virus, (HBV), and (HCV), papillomavirus, and BK polyomavirus. Nosocomial infections Pathogens include: Legionella L i spp and other gram negative bacilli such as Pseudomonas aeruginosa. Gram positive organisms, particularly antimicrobial resistant species such as vancomycin resistant enterococci (VRE) and (MRSA)

5 Infectious considerations in the evaluation of potential organ donors and recipients Viral infection Acute viremia (eg, Herpes simplex virus, adenovirus, lymphocytic choriomeningitis virus, hepatitis A, West Nile virus),active shingles (varicella zoster infection) or herpes virus pneumonitis,acute Epstein Barr virus (mononucleosis),hiv infection (serologic or molecular evidence),active hepatitis B or hepatitis C, Human T cell lymphotropic virus I/ II II (no longer an absolute contraindication in non endemic regions),sars Bacterial infection Ati Active tuberculosis, Untreated t pneumonia, Untreated t syphilis, Multisystem t organ failure due to overwhelming sepsis or gangrenous bowel, Active toxoplasmosis (prophylaxis effective), Fungal and parasite infection Parasitic infection, Active Trypanosoma cruzi, Leishmaniasis, candidiasis, Nocardia, Histoplasmosis, Strongyloidiasis.

6 Common viral infections in solid organ transplant recipients Herpes group Herpes simplex Varicella zoster Epstein Barr virus Cytomegalovirus HHV6 HHV7 HV8/KSHVHV8/KSHV Donor derived West Nile virus Rabies LCMV Hepatitis B Hepatitis C Papillomavirus Polyomavirus BK/JC Respiratory viruses Adenovirus RSV Influenza Parainfluenza Metapneumovirus SARS coronavirus Parvovirus B19 HIV

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

Infection in Renal Transplant Recipients

Infection in Renal Transplant Recipients Chapter Infection in Renal Transplant Recipients Jay A. Fishman John A. Davis Risk of Infection Epidemiological Exposures Net State of Immunosuppression Timetable of Infection First Phase (0 to 4 Weeks

More information

Infections in immunocompromised host

Infections in immunocompromised host Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique

More information

Antimicrobial prophylaxis for transplant recipients. Peter Chin-Hong, MD MAS February 4, 2015

Antimicrobial prophylaxis for transplant recipients. Peter Chin-Hong, MD MAS February 4, 2015 Antimicrobial prophylaxis for transplant recipients Peter Chin-Hong, MD MAS February 4, 2015 Objective To list and understand the approach to three prevention strategies used to prevent infections in transplant

More information

Test Requested Specimen Ordering Recommendations

Test Requested Specimen Ordering Recommendations Microbiology Essentials Culture and Sensitivity (C&S) Urine C&S Catheter Surgical (excluding kidney aspirates) Voided Requisition requirements o Specific method of collection MUST be indicated o Indicate

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on

More information

Types of infections & Mode of transmission of diseases

Types of infections & Mode of transmission of diseases Types of infections & Mode of transmission of diseases Badil dass Karachi King s College of Nursing Types of Infection Community acquired infection: Patient may acquire infection before admission to the

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not

More information

Infection Data: Form Updates

Infection Data: Form Updates Infection Data: Form Updates Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Why is infection data important?

More information

Risky Business Preventing Disease Transmission From Donor Organs. Peter Chin-Hong, MD UCSF September 2012

Risky Business Preventing Disease Transmission From Donor Organs. Peter Chin-Hong, MD UCSF September 2012 Risky Business Preventing Disease Transmission From Donor Organs Peter Chin-Hong, MD UCSF September 2012 Case 1: Something rare? 54 yo WM with HBV/HCV/HCC Day 5: Fever to 102.4, mild frontal HA since time

More information

INFECTIOUS DISEASE. Page 2

INFECTIOUS DISEASE. Page 2 Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic

More information

Infection in Organ Transplantation

Infection in Organ Transplantation American Journal of Transplantation 2017; 17: 856 879 Wiley Periodicals Inc. Comprehensive Review 2017 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.14208

More information

Infections Post-Organ Transplant

Infections Post-Organ Transplant VOLUME 12 CORAM S CONTINUING EDUCATION PROGRAM Infections Post-Organ Transplant It has been established that for most organ recipients, transplant is both life-saving and life-enhancing. Success rates

More information

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our

More information

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group.

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group. Equalis EQA s 2013 Preliminary Schedule For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group. Note: EQA programmes may appear in

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles

More information

Screening of Donor and Recipient Prior to Solid Organ Transplantation

Screening of Donor and Recipient Prior to Solid Organ Transplantation Wiley Periodicals Inc. C 2009 The Authors Journal compilation C 2009 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/j.1600-6143.2009.02888.x Screening

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

Pneumonia in the Immunocompromised Host

Pneumonia in the Immunocompromised Host SIOP PODC Supportive Care Education Presentation Date: 26 th October 2015 Recording Link at www.cure4kids.org: https://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p1bk39ernlb Pneumonia in

More information

Increased Risk Donors. November 1, 2018 BC Kidney Days. Jagbir Gill MD MPH Associate Professor of Medicine UBC

Increased Risk Donors. November 1, 2018 BC Kidney Days. Jagbir Gill MD MPH Associate Professor of Medicine UBC Increased Risk Donors November 1, 2018 BC Kidney Days Jagbir Gill MD MPH Associate Professor of Medicine UBC Median dialysis exposure prior to DDKT Case scenarios Which donors should we accept kidneys

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recomd on national level Not legy binding and not recomd

More information

The Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale

The Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant

More information

M O L E C U L A R G E N E T I C S

M O L E C U L A R G E N E T I C S MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are

More information

Immunohistochemical Confirmation of Infections

Immunohistochemical Confirmation of Infections Immunohistochemical Confirmation of Infections Danny A. Milner, Jr, MD, MSc, FCAP The Brigham and Women s Hospital Harvard Medical School Boston, Masschusetts USA Judicious Use of Immunohistochemistry

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

Appropriate utilization of the microbiology laboratory. 11 April 2013

Appropriate utilization of the microbiology laboratory. 11 April 2013 Appropriate utilization of the microbiology laboratory 11 April 2013 Lecture Plan Revision of infectious disease Triad of infectious disease Interaction between host and infectious agent Pathogenesis Phases

More information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University

More information

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23 MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23 Chapter 21 I. MICROBIAL DISEASES OF THE SKIN A. Defense 1. Keratin 2. Sweat ducts 3. Oil glands

More information

Multiple Choice Questions - Paper 1

Multiple Choice Questions - Paper 1 Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could

More information

Fresh Citrus Disinfectant Cleaner

Fresh Citrus Disinfectant Cleaner SUMMARY OF ANTIMICROBIAL ACTIVITY Fresh Citrus Disinfectant Cleaner Description Fresh Citrus Disinfectant Cleaner is an effective economical 4 ounce per gallon disinfectant, specifically designed for hospitals,

More information

5/9/2015. Disclosures. Infection in the (non-hiv) Immunocompromised Patient. Outline. Case #1. None. Critical Care Medicine May 2015

5/9/2015. Disclosures. Infection in the (non-hiv) Immunocompromised Patient. Outline. Case #1. None. Critical Care Medicine May 2015 Disclosures None Infection in the (non-hiv) Immunocompromised Patient Critical Care Medicine May 2015 Jennifer Babik, MD, PhD Assistant Clinical Professor Division of Infectious Diseases, UCSF Outline

More information

Microbiology EQA Product Portfolio

Microbiology EQA Product Portfolio Labquality EQAS Microbiology EQA Product Portfolio Clinically relevant external quality assessment program for microbiology Bacterial serology Bacteriology Mycology Parasitology Preanalytics Virology Labquality

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legally binding More stringent - recommended Not legally binding and not recommended Non-reproductive tissues and cells

More information

Version number CAT 2016/01

Version number CAT 2016/01 Version number CAT 2016/01 Contents An Introduction to the QCMD EQA Schemes 4 Disease Groups Blood Borne Virus 5 Central Nervous System 5 Congenital Infections 6 Drug Resistance 6 Exotic/Emerging Diseases

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A AAP. See American Academy of Pediatrics (AAP) Acyclovir dosing in infants, 185 187 American Academy of Pediatrics (AAP) COFN of, 199 204 Amphotericin

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal catastrophes in ICU, 1017 1044. See also specific types, e.g., Abdominal compartment syndrome treatment of, 1032 1037 antimicrobial,

More information

Potential Reimbursement CPT Codes

Potential Reimbursement CPT Codes BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may

More information

Isolation Precautions in Clinics

Isolation Precautions in Clinics Purpose Audience General principles Possible Exposures To define isolation precautions in a clinic setting. Clinics Isolation status should be determined primarily by the suspected disease and/or pathogen.

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Non-reproductive tissues and cells VIRAL

More information

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk

More information

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory This appendix contains a list of agents that, when reasonably anticipated to be present, require a laboratory to comply

More information

Viruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae

Viruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,

More information

PUO in the Immunocompromised Host: CMV and beyond

PUO in the Immunocompromised Host: CMV and beyond PUO in the Immunocompromised Host: CMV and beyond PUO in the immunocompromised host: role of viral infections Nature of host defect T cell defects Underlying disease Treatment Nature of clinical presentation

More information

Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel

Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel David T. Kuhar, M.D. Medical Epidemiologist HICPAC Meeting June 6, 2013 National Center for Emerging and Zoonotic Infectious

More information

AFFECTED STAKEHOLDERS

AFFECTED STAKEHOLDERS POLICY STATEMENT All patients will be assessed for infectious diseases or pathogens upon presentation in all settings. Proper transmission-based precautions will be initiated based on clinical presentation

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing SUMMARY OF ANTIMICROBIAL ACTIVITY ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing Description One Step is an effective economical 4 ounce per gallon disinfectant, specifically

More information

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes

More information

Infection Control Manual Residential Care Part 3 Infection Control Standards IC6: Additional Precautions

Infection Control Manual Residential Care Part 3 Infection Control Standards IC6: Additional Precautions IC6: 0110 Appendix I Selection Table Infection Control Manual esidential Care IC6: Additional Legend: outine Practice * reportable to Public Health C - Contact ** reportable by Lab D - Droplet A - Airborne

More information

Infection in the Bone Marrow Transplant Recipient and Role of the Microbiology Laboratory in Clinical Transplantation

Infection in the Bone Marrow Transplant Recipient and Role of the Microbiology Laboratory in Clinical Transplantation CLINICAL MICROBIOLOGY REVIEWS, Apr. 1997, p. 277 297 Vol. 10, No. 2 0893-8512/97/$04.00 0 Copyright 1997, American Society for Microbiology Infection in the Bone Marrow Transplant Recipient and Role of

More information

EQA PROGRAMME CATALOGUE. Version number CAT2019/01

EQA PROGRAMME CATALOGUE.   Version number CAT2019/01 2019 EQA PROGRAMME CATALOGUE www.qcmd.org Version number CAT2019/01 Contents An Introduction to the QCMD EQA Schemes 5 EQA Groups Blood Borne Virus 6 Central Nervous System 6 Congenital Infections 7 Drug

More information

Manitoba Monthly Surveillance Unit Report

Manitoba Monthly Surveillance Unit Report Manitoba Monthly Surveillance Unit Report Reported up to June 30, 2012 Highlights: 1. Antimicrobial Resistant Organisms Together Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile

More information

Students. Exhibit - Reporting and Exclusion Requirements for Common Communicable Disease. Reporting Mandated to Local Health Authority

Students. Exhibit - Reporting and Exclusion Requirements for Common Communicable Disease. Reporting Mandated to Local Health Authority August 2003 7:280-E2 Students Exhibit - Reporting and Exclusion Requirements for Common Communicable s Animal Bites (potential for rabies) Bacterial Vaginosis Chancroid As soon as possible, but within

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

enter the room. Persons immune from previous varicella infection may enter the room without a mask. Those immune by adenoviruses, influenza viruses.

enter the room. Persons immune from previous varicella infection may enter the room without a mask. Those immune by adenoviruses, influenza viruses. All clients admitted to the hospital automatically are considered to be on standard precautions. The diseases listed below require standard precautions plus additional precautions that are noted in the

More information

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. # Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic

More information

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

PATHOGEN DETECTION WITH THE FILMARRAY

PATHOGEN DETECTION WITH THE FILMARRAY PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

Overview of Microbiology. James D. Dick, PhD Johns Hopkins University

Overview of Microbiology. James D. Dick, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Epidemiology and Laboratory Diagnosis of Fungal Diseases Medical Mycology (BIOL 4849) Summer 2007 Dr. Cooper Epidemiology of Mycoses Epidemiology and Laboratory Diagnosis of Fungal Diseases Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories

More information

Transplantation, Virology Division, SEALS Microbiology

Transplantation, Virology Division, SEALS Microbiology Transplantation, Immunosuppression, Infection Viruses in May 2010 Bill Rawlinson Virology Division, SEALS Microbiology w.rawlinson@unsw.edu.au OUTLINE Transplant infections donor and recipient Types Pathogenesis

More information

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada Canada Communicable Disease Report ISSN 1188-4169 Date of publication: October 1998 Volume 24S7 Supplement Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada 1989 to 1996 Our

More information

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario Increase in Locally-Acquired Cyclosporiasis Cases in Ontario Update to York Region health care providers as of July 31, 2018 Ontario is experiencing an increase in the number of Cyclospora infections.

More information

Version number CAT2018/02

Version number CAT2018/02 www.qcmd.org Version number CAT2018/02 Contents An Introduction to the QCMD EQA Schemes 5 EQA Groups Blood Borne Virus 6 Central Nervous System 6 Congenital Infections 7 Drug Resistance 7 Exotic/Emerging

More information

CNS Infections in the Pediatric Age Group

CNS Infections in the Pediatric Age Group CNS Infections in the Pediatric Age Group Introduction CNS infections are frequently life-threatening In the Philippines, bacterial meningitis is one of the top leading causes of mortality in children

More information

Report on the Performance of the. VidaShield System

Report on the Performance of the. VidaShield System Report on the Performance of the VidaShield System By Dr. Wladyslaw J. Kowalski Prepared for Arcalux Corporation, 6306 Alder Drive, Houston, TX, 77081 Executive Summary The superior performance of the

More information

Pulmonary Disease in the Immunocompromised Host (Second of Two Parts)*

Pulmonary Disease in the Immunocompromised Host (Second of Two Parts)* Subject Review Pulmonary Disease in the Immunocompromised Host (Second of Two Parts)* WALTER R. WILSON, M.D., FRANKLIN R. COCKERILL III, M.D., Division of Infectious Diseases and Internal Medicine; EDWARD

More information

الحترمونا من خري الدعاء

الحترمونا من خري الدعاء الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or

More information

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone.

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone. CMV Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone. CMV inclusions are often present in a very patchy distribution Carefully examine all levels CMV CMV

More information

p. 111 p. 185 p. 197 p. 238

p. 111 p. 185 p. 197 p. 238 Editorial Board Contributors Preface General Methods p. 1 General Methods: Antibody-Based and Molecular p. 3 Introduction p. 5 Antibody-Based Methods p. 6 p. xiii p. xv p. xxv Introduction to Molecular

More information

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents Objectives Atypical Pneumonia K. Sue Kehl, Ph.D., D(ABMM) Associate Professor, Pathology Medical College of Wisconsin Associate Director of Clinical Pathology & Technical Director of Microbiology, Children's

More information

IP Lab Webinar 8/23/2012

IP Lab Webinar 8/23/2012 2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests

More information

PHAR 6724: Introduction to the Immune System and Infectious Disease

PHAR 6724: Introduction to the Immune System and Infectious Disease PHAR 6724: Introduction to the Immune System and Infectious Disease Course Syllabus Spring 2018 3.1 Credits This course adheres to the items listed in the College of Pharmacy Central Syllabus: https://docs.google.com/a/umn.edu/document/d/1artq5e1rbzxe8letwo7be8k8snzaegmmz_qcw8yj-ii/edit?pli=1

More information

I.B.3. Modes of transmission I.B.3.a. Contact transmission I.B.3.a.i. Direct contact transmission I.B.3.a.ii. Indirect contact transmission

I.B.3. Modes of transmission I.B.3.a. Contact transmission I.B.3.a.i. Direct contact transmission I.B.3.a.ii. Indirect contact transmission I.B.3. Modes of transmission Several classes of pathogens can cause infection, including bacteria, viruses, fungi, parasites, and prions. The modes of transmission vary by type of organism and some infectious

More information

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and

More information

8/11/2015. Febrile neutropenia Bone marrow transplant Immunosuppressant medications

8/11/2015. Febrile neutropenia Bone marrow transplant Immunosuppressant medications Dean Van Loo Pharm.D. Febrile neutropenia Bone marrow transplant Immunosuppressant medications Steroids Biologics Antineoplastic Most data from cancer chemotherapy Bone marrow suppression Fever is the

More information

INFECTIOUS DISEASES. Theory credits: 3.5

INFECTIOUS DISEASES. Theory credits: 3.5 Total credits: 8.5 INFECTIOUS DISEASES Theory credits: 3.5 Practical credits: 5 GENERAL OBJECTIVES During the training period students are expected to acquire the theoretical knowledge and clinical skills

More information

Appendix E1. Epidemiology

Appendix E1. Epidemiology Appendix E1 Epidemiology Viruses are the most frequent cause of human infectious diseases and are responsible for a spectrum of illnesses ranging from trivial colds to fatal immunoimpairment caused by

More information

The Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro

The Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro The Study of Congenital Infections A/Prof. William Rawlinson Dr. Sian Munro Current Studies SCIP Study of Cytomegalovirus (CMV) Infection in Pregnancy ASCI Amniotic Fluid Study of Congenital Infections

More information

Viral Infection. Pulmonary Infections with Respiratory Viruses. Wallace T. Miller, Jr., MD. Objectives: Viral Structure: Significance:

Viral Infection. Pulmonary Infections with Respiratory Viruses. Wallace T. Miller, Jr., MD. Objectives: Viral Structure: Significance: Viral Infection Wallace T. Miller, Jr., MD Pulmonary Infections with Respiratory Viruses Wallace T. Miller, Jr. MD Associate Professor of Radiology and Pulmonary and Critical Care Medicine University of

More information

UVGI APPLIED DURING ORTHOPEDIC SURGERY AND THE RATE OF INFECTION

UVGI APPLIED DURING ORTHOPEDIC SURGERY AND THE RATE OF INFECTION UVGI APPLIED DURING ORTHOPEDIC SURGERY AND THE RATE OF INFECTION UVGI BASICSB Mercury Vapor lamps produce 253.7 nm radiation which breaks down the DNA and RNA of microorganisms, scrambling their genetic

More information

Update on the development of clinical diagnostic run controls at NIBSC. Neil Almond Division of Virology

Update on the development of clinical diagnostic run controls at NIBSC. Neil Almond Division of Virology Update on the development of clinical diagnostic run controls at NIBSC Neil Almond Division of Virology BACKGROUND Molecular techniques are increasingly being used for microbiological diagnoses Assays

More information

Imaging in Infectious Disease- North America: Imaging and Health Care-Associated Infections

Imaging in Infectious Disease- North America: Imaging and Health Care-Associated Infections Imaging in Infectious Disease- North America: Imaging and Health Care-Associated Infections Paul Babyn University of Saskatchewan I have no disclosures Outline Introduction Common HAIs in Children Becoming

More information

CRITICAL VALUES, SIGNIFICANT FINDINGS LIST and STAT RESULTS

CRITICAL VALUES, SIGNIFICANT FINDINGS LIST and STAT RESULTS Page 1 of 6 Affected Sites: X Enterprise Chandler Good Samaritan CRITICAL VALUES: s are defined as an analytic result that suggests a clinical condition that may be lifethreatening and may require immediate

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Topics To Be Discussed. Infections after transplantation. Lack of Change in Infectious Mortality. Decreasing Infectious Mortality in Subsequent

Topics To Be Discussed. Infections after transplantation. Lack of Change in Infectious Mortality. Decreasing Infectious Mortality in Subsequent Topics To Be Discussed Infections after transplantation 衛福部疾病管制署中區傳染病防治醫療網王任賢指揮官 How are we doing in transplantation? Review basic precepts of transplant infections Discuss some classic transplant pathogens:

More information

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH Policy # MI/EDU/08/04/v01 Page1 of 13 Section: Subject Title: Resident Objectives at MSH Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director Revision Date: SPECIMENS

More information

Abnormal Liver Tests After Liver Transplantation

Abnormal Liver Tests After Liver Transplantation REVIEW Abnormal Liver Tests After Liver Transplantation Andrew Fedoravicius, M.D., and Michael Charlton, M.D., F.R.C.P. GENERAL CONSIDERATIONS After liver transplantation (LTx), nearly every recipient

More information

Chapters 21-26: Selected Viral Pathogens

Chapters 21-26: Selected Viral Pathogens Chapters 21-26: Selected Viral Pathogens 1. DNA Viral Pathogens 2. RNA Viral Pathogens 1. DNA Viral Pathogens Smallpox (pp. 623-4) Caused by variola virus (dsdna, enveloped): portal of entry is the respiratory

More information

Cleaning for Additional Precautions Table symptom based

Cleaning for Additional Precautions Table symptom based for Additional Precautions Table symptom based The need to wear personal protective equipment () for Routine Practices is dependent on the risk of contact or contamination with blood or body fluids. should

More information

Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3

Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3 Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3 AY16-17 COURSE DESCRIPTION: A course that introduces Immunology, Virology, Mycology, and Parasitology as well as the immunological

More information

Perform Gram stain only. Select Survey D5, Gram Stain

Perform Gram stain only. Select Survey D5, Gram Stain www.cap.org Bacteriology This flowchart is provided as a guide for ordering the appropriate Bacteriology Surveys for your laboratory s testing menu. In order to meet CLIA requirements for the subspecialty

More information

Introduction: Infections in Solid Organ Transplantation

Introduction: Infections in Solid Organ Transplantation American Journal of Transplantation 2013; 13: 3 8 Wiley Periodicals Inc. Special Article C Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.12093

More information

SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH

SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH HPH 102: MEDICAL MICROBIOLOGY DATE: 7/12/2015 TIME:10:30-12:30PM INSTRUCTIONS

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

+ Intermittent shedding in urine, + Urinary tract

+ Intermittent shedding in urine, + Urinary tract Table 16.3 Examples of s in humans Microorganism Site of persistence Infectiousness of microorganism Viruses Consequence Herpes simplex Dorsal root ganglia Activation, cold sore + Salivary glands + Not

More information